The "The Pharma Mini MBA (July 8th - July 10th, 2026)" has been added to ResearchAndMarkets.com's offering. The Pharma Mini MBA is a unique, three-day virtual management program tailor-made for ...

For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...

The ready-to-use pharmaceutical packaging market offers significant growth driven by the demand for pre-sterilized containers ...

Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. Gilead plans to develop Ouro’s lead drug candidate, gamgertamig, alongside a Belgian pharma company. Nvidia ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

In October 2024, the announcement of the Nobel Prize in Chemistry left a symbolic scene in the pharmaceutical and biotech ...

In this week’s edition of InnovationRx, we look at the first robotic cataract surgeries in humans, the underbelly of ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug ...

Royalty Pharma Plc (NASDAQ:RPRX) is one of the most undervalued biotech stocks to buy right now. Royalty Pharma Plc ...